 Prospective evaluation ciprofloxacin versus piperacillin amikacin empiric antibiotic therapy febrile granulocytopenic cancer patients lymphomas solid tumors European Organization Research Treatment Cancer International Antimicrobial Therapy Cooperative Group Empiric therapy febrile granulocytopenic patients mandatory monotherapy safe alternative fluoroquinolones useful agents indication controversial issues use monotherapy intravenous ciprofloxacin mg therapy piperacillin amikacin febrile granulocytopenic patients solid tumor lymphoma study patients ciprofloxacin overall success rate patients piperacillin amikacin patients versus patients Patients gram-positive coccal bacteremia poor outcome therapy patients ciprofloxacin therapy none patients piperacillin amikacin Death primary infection protocol therapy patients ciprofloxacin piperacillin amikacin study use dose intravenous ciprofloxacin empiric monotherapy fever granulocytopenic patients